ISTURISA DIN 02558912
Status: Marketed
Holder: RECORDATI RARE DISEASES CANADA INC
Molecule: OSILODROSTAT (OSILODROSTAT PHOSPHATE)
Health Canada record
| Active ingredient(s) | OSILODROSTAT (OSILODROSTAT PHOSPHATE) 1 MG |
|---|---|
| Dosage form | Tablet |
| Route | Oral |
| Schedule | PRESCRIPTION |
| Class | Human |
| ATC | H02CA02 OSILODROSTAT |
| Original market date | 17-Dec-2025 |
| Current status date | 17-Dec-2025 |
| Source | Health Canada DPD |
Establishment licence of the holder
Recordati Rare Diseases Canada Inc. — licence 102167, currently licensed, last inspection rating C (2022-08-17).
No Canadian shortage report is currently matched to this DIN.
Other Canadian products containing OSILODROSTAT (OSILODROSTAT PHOSPHATE)
| DIN | Product | Company | Form | Strength | Status |
|---|---|---|---|---|---|
| 02558920 | ISTURISA | RECORDATI RARE DISEASES CANADA INC | Tablet | OSILODROSTAT (OSILODROSTAT PHOSPHATE) 5 MG | Marketed |
| 02558939 | ISTURISA | RECORDATI RARE DISEASES CANADA INC | Tablet | OSILODROSTAT (OSILODROSTAT PHOSPHATE) 10 MG | Marketed |
Notices of Compliance
| NOC | Date | Submission | Reason |
|---|---|---|---|
| 35611 | 2025-07-03 | New Drug Submission (NDS) |